Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States
Clicks: 306
ID: 271743
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
306 views
41 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #9 of 17 articles by views in Alcohol and alcoholism (Oxford, Oxfordshire)
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (15 words).
Try re-searching for a better abstract.
| Reference Key |
jc2020alcoholapproval
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Garbutt JC;; |
| Journal | Alcohol and alcoholism (Oxford, Oxfordshire) |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
United States
meta-analysis as topic
france
baclofen / therapeutic use*
alcoholism / drug therapy*
gaba-b receptor agonists / therapeutic use
pmid:31761948
doi:10.1093/alcalc/agz084
james c garbutt
drug approval*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.